While taking Eliquis (apixaban), is an INR of 0.94 within the therapeutic range?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

INR Monitoring is Not Applicable for Apixaban

An INR of 0.94 while taking Eliquis (apixaban) is neither "good" nor "bad" because INR should not be used to monitor apixaban therapy—the two tests measure completely different things. 1, 2, 3

Why INR is Irrelevant for Apixaban

  • INR was specifically designed and validated only for monitoring warfarin therapy, not direct oral anticoagulants like apixaban 1, 2, 3
  • The INR system uses calibration standards based on vitamin K antagonist effects, which do not apply to factor Xa inhibitors like apixaban 4
  • Apixaban does affect INR values unpredictably, but this effect has no correlation with the drug's actual anticoagulant activity or your bleeding/clotting risk 4, 5, 6

What Happens to INR on Apixaban

  • Studies show apixaban typically causes mild INR elevation (median 1.4-1.7), but this varies widely and is clinically meaningless 5, 6, 7
  • Your INR of 0.94 is actually below the normal laboratory range (typically 0.9-1.1), which paradoxically could occur despite therapeutic apixaban levels 6
  • The INR cannot tell you if apixaban is working properly or if you're at risk for bleeding or clotting 4, 7

What You Should Monitor Instead

For routine apixaban monitoring, focus on these parameters 1, 3:

  • Renal function (creatinine/CrCl) at least annually—apixaban clearance depends 27% on kidney function 3, 8, 5
  • Hepatic function annually—liver impairment affects apixaban metabolism 3, 8
  • Body weight and age—dose adjustments required if you meet 2+ criteria: age ≥80 years, weight ≤60 kg, or creatinine ≥1.5 mg/dL 8, 9
  • Bleeding symptoms—any unusual bruising, blood in urine/stool, or prolonged bleeding 10, 8

When Apixaban Levels Actually Matter

Specific anti-factor Xa assays (not INR) should be used only in these situations 4:

  • Life-threatening bleeding requiring reversal consideration
  • Emergency surgery within 24-48 hours
  • Suspected overdose or toxicity
  • Extreme renal impairment (CrCl <15 mL/min)

Common Pitfall to Avoid

Do not let clinicians adjust your apixaban dose or add/stop the medication based on INR values 4, 6, 7. This is a frequent error that can lead to either under-anticoagulation (stroke risk) or over-anticoagulation (bleeding risk). The INR of 0.94 provides zero useful information about whether your apixaban is working correctly.

References

Research

Evaluation of the Effect of Apixaban on INR in the Inpatient Population.

Journal of cardiovascular pharmacology and therapeutics, 2019

Guideline

Co-prescription of Lexapro (Escitalopram) and Apixaban

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.